Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
EBIT Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 121.16-44.9292.58-57.38-14.14

What is the latest EBIT Growth ratio of NGL FINECHEM ?

The latest EBIT Growth ratio of NGL FINECHEM is 121.16 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar2026121.16
Mar2025-44.92
Mar202492.58
Mar2023-57.38
Mar2022-14.14

How is EBIT Growth of NGL FINECHEM Trending?

Years EBIT Growth % Change
Mar2026 121.16
Positive
Mar2025 -44.92
Negative
Mar2024 92.58
Positive
Mar2023 -57.38
Negative
Mar2022 -14.14 -

Other Financial Ratios of NGL FINECHEM


Compare EBIT Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,783.3 Cr 1% 2.3% 92.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr -0.3% -3.1% 12.8% Stock Analytics
DIVIS LABORATORIES ₹251,531.0 Cr -1.3% 2.2% 57.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,957.0 Cr -1.3% -2.4% 33.3% Stock Analytics
CIPLA ₹111,729.0 Cr 0.2% -2.5% -9.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,335.0 Cr 3.3% 6.1% -6.5% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

1%

2.3%

92.6%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses